INSIGHTS ON DRUG DEVELOPMENT
-
Modifying The Micro-Environment To Improve Dissolution Rate
<p>Discover how modifying the micro-environment with targeted excipients can significantly enhance the dissolution rate of poorly soluble drugs using conventional manufacturing methods.</p>
-
Formulation Development For Therapeutic Oligonucleotides
Discover how expert formulation and analytical support enable the development of stable, injectable oligonucleotide therapies across diverse delivery routes and molecule types.
-
EMA Support For Rare Disease Therapies
Review how the EMA supports rare disease drug development through regulatory and financial incentives for therapies that meet strict eligibility and ongoing compliance criteria.
-
The Role Of A Consulting Firm In The IND Process
Navigate the complex IND process with expert guidance and discover how early FDA engagement can accelerate your path to clinical trials.
-
Choosing The Right PBMCS For Your Research And Product Development Needs6/10/2025
Enhance the success of your research and cell therapy programs by sourcing PBMCs with proven functional performance and donor-specific insights.
-
Flow Chemistry Vs. Batch Processes6/10/2025
Explore how continuous flow chemistry can accelerate your chemical development with greater efficiency, safety, and sustainability compared to traditional batch processes.
-
Linking Clinical Correlates To Cell Therapy Outcomes6/9/2025
Streamline cell therapy development by transforming complex cellular characteristics into a predictive, multiparametric metric that guides the selection of high-potential starting material.
-
Injection Site Reaction Screening Methodology6/6/2025
Optimize drug formulations for solubility at physiological pH to reduce injection site reactions, enable high-concentration dosing, and enhance patient comfort and compliance.
DRUG DEVELOPMENT SOLUTIONS
-
By partnering with us, you gain access to cutting-edge facilities and a team of experienced scientists with deep expertise in a wide range of therapeutic areas.
-
Societal specializes in modified-release formulations, including those for high potent and DEA controlled substances.
-
Learn how this partnership improves flexibility for customers, offers dedicated project teams, and enables a bespoke service that is tailored to each development program.
-
With a suite of analytical services and capabilities, we equip our clients with the insights and tools needed for successful biologics characterization and phase-appropriate process development.
-
Explore an approach that accelerates your project through key milestones with a technology transfer process that ensures a fast start and process analytical technology that increases efficiency and reduces cost.